.png)
Elevate your infection control strategy with a faster and innovative molecular solution. Diasorin’s Simplexa® C. auris Direct is the first FDA authorized assay for the detection of Candida auris colonization that aids in the infection prevention and control of C. auris in healthcare settings, enabling better clinical and economic outcomes.
